280 related articles for article (PubMed ID: 31615010)
21. The therapeutic effects of Stauntonia hexaphylla in benign prostate hyperplasia are mediated by the regulation of androgen receptors and 5α-reductase type 2.
Hong GL; Park SR; Jung DY; Karunasagara S; Lee KP; Koh EJ; Cho K; Park SS; Jung JY
J Ethnopharmacol; 2020 Mar; 250():112446. PubMed ID: 31812646
[TBL] [Abstract][Full Text] [Related]
22. Ulmus macrocarpa Hance improves benign prostatic hyperplasia by regulating prostatic cell apoptosis.
Rho J; Seo CS; Park HS; Wijerathne CU; Jeong HY; Moon OS; Seo YW; Son HY; Won YS; Kwun HJ
J Ethnopharmacol; 2019 Apr; 233():115-122. PubMed ID: 30508623
[TBL] [Abstract][Full Text] [Related]
23. Diacerein provokes apoptosis, improves redox balance, and downregulates PCNA and TNF-α in a rat model of testosterone-induced benign prostatic hyperplasia: A new non-invasive approach.
Rasheed RA; Sadek AS; Khattab RT; Elkhamisy FAA; Abdelfattah HA; Elshaer MMA; Almutairi SM; Hussein DS; Embaby AS; Almoatasem MAM
PLoS One; 2023; 18(11):e0293682. PubMed ID: 37943844
[TBL] [Abstract][Full Text] [Related]
24. Activation of cGMP/PKG/p65 signaling associated with PDE5-Is downregulates CCL5 secretion by CD8
Jin S; Xiang P; Liu J; Yang Y; Hu S; Sheng J; He Q; Yu W; Han W; Jin J; Peng J
Prostate; 2019 Jun; 79(8):909-919. PubMed ID: 30958912
[TBL] [Abstract][Full Text] [Related]
25.
Kim M; Tran P; Yin J; Song J; Kim H
Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839177
[TBL] [Abstract][Full Text] [Related]
26. Labda-8(17),12,14-trien-19-oic acid contained in fruits of Cupressus sempervirens suppresses benign prostatic hyperplasia in rat and in vitro human models through inhibition of androgen and STAT-3 signaling.
Verma V; Sharma V; Singh V; Kumar R; Khan MF; Singh AK; Sharma R; Arya KR; Maikhuri JP; Dalela D; Maurya R; Gupta G
Phytother Res; 2014 Aug; 28(8):1196-203. PubMed ID: 24399792
[TBL] [Abstract][Full Text] [Related]
27. Anti-Proliferative Effects of Standardized
Jin BR; Cheon SY; Kim HJ; Kim MS; Lee KH; An HJ
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33334082
[No Abstract] [Full Text] [Related]
28. Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.
Habib FK; Ross M; Tate R; Chisholm GD
Clin Endocrinol (Oxf); 1997 Feb; 46(2):137-44. PubMed ID: 9135694
[TBL] [Abstract][Full Text] [Related]
29. Role of PPAR-α agonist fenofibrate in the treatment of induced benign prostatic hyperplasia with dysplastic changes in rats.
Refaie MMM; Rifaai RA; Zenhom NM
Fundam Clin Pharmacol; 2018 Dec; 32(6):617-626. PubMed ID: 29862557
[TBL] [Abstract][Full Text] [Related]
30. Curcuma oil ameliorates benign prostatic hyperplasia through suppression of the nuclear factor-kappa B signaling pathway in rats.
Wang S; Li Y; Li W; Zhang K; Yuan Z; Cai Y; Xu K; Zhou J; Du Z
J Ethnopharmacol; 2021 Oct; 279():113703. PubMed ID: 33340599
[TBL] [Abstract][Full Text] [Related]
31. Dapoxetine attenuates testosterone-induced prostatic hyperplasia in rats by the regulation of inflammatory and apoptotic proteins.
Sayed RH; Saad MA; El-Sahar AE
Toxicol Appl Pharmacol; 2016 Nov; 311():52-60. PubMed ID: 27687055
[TBL] [Abstract][Full Text] [Related]
32. Ellagic acid improves benign prostate hyperplasia by regulating androgen signaling and STAT3.
Park WY; Song G; Park JY; Ahn KS; Kwak HJ; Park J; Lee JH; Um JY
Cell Death Dis; 2022 Jun; 13(6):554. PubMed ID: 35715415
[TBL] [Abstract][Full Text] [Related]
33. Umbelliferone Ameliorates Benign Prostatic Hyperplasia by Inhibiting Cell Proliferation and G1/S Phase Cell Cycle Progression through Regulation of STAT3/E2F1 Axis.
Kim HJ; Jin BR; An HJ
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445725
[TBL] [Abstract][Full Text] [Related]
34. Targeting benign prostate hyperplasia treatments: AR/TGF-β/NOX4 inhibition by apocynin suppresses inflammation and proliferation.
Jin BR; Kim HJ; Na JH; Lee WK; An HJ
J Adv Res; 2024 Mar; 57():135-147. PubMed ID: 37061215
[TBL] [Abstract][Full Text] [Related]
35. Fenofibrate mitigates testosterone induced benign prostatic hyperplasia via regulation of Akt/FOXO3a pathway and modulation of apoptosis and proliferation in rats.
Kortam MA; Alawady AS; Hamid Sadik NA; Fathy N
Arch Biochem Biophys; 2022 Jul; 723():109237. PubMed ID: 35430215
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the therapeutic effect against benign prostatic hyperplasia and the active constituents from Epilobium angustifolium L.
Deng L; Zong W; Tao X; Liu S; Feng Z; Lin Y; Liao Z; Chen M
J Ethnopharmacol; 2019 Mar; 232():1-10. PubMed ID: 30529422
[TBL] [Abstract][Full Text] [Related]
37. Pao Pereira Extract Attenuates Testosterone-Induced Benign Prostatic Hyperplasia in Rats by inhibiting 5α-Reductase.
Liu J; Fang T; Li M; Song Y; Li J; Xue Z; Li J; Bu D; Liu W; Zeng Q; Zhang Y; Yun S; Huang R; Yan J
Sci Rep; 2019 Dec; 9(1):19703. PubMed ID: 31873149
[TBL] [Abstract][Full Text] [Related]
38. Effects of red ginseng oil(KGC11
Lee JY; Kim S; Kim S; Kim JH; Bae BS; Koo GB; So SH; Lee J; Lee YH
J Ginseng Res; 2022 May; 46(3):473-480. PubMed ID: 35600774
[TBL] [Abstract][Full Text] [Related]
39. Cynanchum wilfordii Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia by Regulating 5α-Reductase and Androgen Receptor Activities in a Rat Model.
Lee G; Shin J; Choi H; Jo A; Pan S; Bae D; Lee Y; Choi C
Nutrients; 2017 Sep; 9(10):. PubMed ID: 28953224
[TBL] [Abstract][Full Text] [Related]
40. The extract of Celtis choseniana Nakai alleviates testosterone-induced benign prostatic hyperplasia through inhibiting 5α reductase type 2 and the Akt/NF-κB/AR pathway.
Hong GL; Kim TW; Lee HJ; Kim YJ; Kim KH; Jung JY
Chin J Nat Med; 2022 Jul; 20(7):518-526. PubMed ID: 35907650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
